A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Cited by (627)

Items 301–400 of 627

1. BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study
   Régis Goulart Rosa, Maicon Falavigna, Josélia Larger Manfio, Cintia Laura Pereira de Araújo, Mirian Miranda Cohen, Gynara Rezende Gonzalez do Valle Barbosa, Ana Paula de Souza, Fernanda Kelly Romeiro Silva, Daniel Sganzerla, Mariana Motta Dias da Silva et al. · 2023 · Vaccine
2. Neutralization and binding antibody response to second bivalent COVID ‐19 vaccination in nursing home residents
   Oladayo Ayobami Oyebanji, Yasin Abul, Brigid M. Wilson, Jürgen Bosch, Elise M. Didion, Alexandra Paxitzis, Nicholas Sundheimer, Vaishnavi Ragavapuram, Dennis J. Wilk, Debbie Keresztesy et al. · 2023 · Journal of the American Geriatrics Society
3. Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine
   Eliel Nham, Jineui Kim, Jungmin Lee, Heedo Park, Jeonghun Kim, Sohyun Lee, Jaeuk Choi, Kyung Taek Kim, Jin Gu Yoon, Soon Young Hwang et al. · 2023 · Immune Network
4. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
   A. Lianne Messchendorp, Jan‐Stephan Sanders, Alferso C Abrahams, Fréderike J. Bemelman, Pim Bouwmans, René M. A. van den Dorpel, Luuk B. Hilbrands, Céline Imhof, Marlies E. J. Reinders, Theo Rispens et al. · 2024 · Viruses
5. Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients
   Saskia Bronder, Janine Mihm, Rebecca Urschel, Verena Klemis, Tina Schmidt, Stefanie Marx, Amina Abu‐Omar, Franziska Hielscher, Candida Guckelmus, Marek Widera et al. · 2024 · npj Vaccines
6. Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave – a nested case-control study among vaccinated adults in Sweden
   Fredrik Kahn, Carl Bonander, Mahnaz Moghaddassi, Claus Bohn Christiansen, Louise Bennet, Ulf P. Malmqvist, Malin Inghammar, Jonas Björk · 2024 · IJID Regions
7. Evaluation of Long-Term Adaptive Immune Responses Specific to SARS-CoV-2: Effect of Various Vaccination and Omicron Exposure
   Hyunhye Kang, Jin Hwan Jung, Geon Young Ko, Jihyun Lee, Eun‐Jee Oh · 2024 · Vaccines
8. Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
   Pedro Cruz, Jie Min Lam, Jehad Abdalla, Samira Bell, Jola Bytyci, Tal Brosh‐Nissimov, John S. Gill, Ghady Haidar, Michael P. Hoerger, ‪Yasmin Maor‬‏ et al. · 2024 · Vaccines
9. RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques
   Hélène Letscher, Delphine Guilligay, Grégory Effantin, Axelle Amen, Guidenn Sulbarán, Judith A. Burger, Laëtitia Bossevot, Laura Junges, Marco Léonec, Julie Morin et al. · 2025 · npj Vaccines
10. Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development
    Yaru Jia, Ziran Zhou, Luksika Jiramonai, Jianxin Chen, Qian Hua, Mengliang Zhu, Jinchao Zhang, Xing‐Jie Liang · 2025 · Coordination Chemistry Reviews
11. Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies
    Irene Santamaria-Castro, Rocío Leiva-Rebollo, Sonia Marín‐Wong, Jose M. Jiménez-Guardeño, Ana Maria Ortega‐Prieto · 2025 · Microbiology and Molecular Biology Reviews
12. Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
    Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Victor Arendt, Georges Gilson, Thérèse Staub, Carole Seguin‐Devaux, Danielle Perez-Bercoff · 2023 · Current Issues in Molecular Biology
13. Understanding the Omicron Variant in the COVID-19 Pandemic
    Safae El Mazouri, Tarik Aanniz, Sara Louati, Lahcen Belyamani, Rachid El Jaoudi, Mouna Ouadghiri · 2023 · IntechOpen eBooks
14. The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report
    Ssu-Yu Chen, Chien‐Yu Lin, Hsin Chi, Shun‐Long Weng, Sung-Tse Li, Yu‐Lin Tai, Ya-Ning Huang, Hsiang Yu Huang, Chao‐Hsu Lin, Nan‐Chang Chiu · 2023 · Life
15. Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial
    Avika Dixit, Richard Bennett, Kashif Ali, Carl Griffin, Robert A. Clifford, Mark A. Turner, Rosanne Poston, Kelly Hautzinger, Anne M. Yeakey, Bethany Girard et al. · 2024 · The Lancet Infectious Diseases
16. Recent approaches in computational modelling for controlling pathogen threats
    John A. Lees, Timothy Russell, Liam P. Shaw, Joel Hellewell · 2024 · Life Science Alliance
17. The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United States
    Michele A. Kohli, Michael Maschio, Amy Lee, Kelly Fust, Nicolas Van de Velde, Philip O. Buck, Milton C. Weinstein · 2022 · Journal of Medical Economics
18. The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions
    Eva Zhang, Britt Christensen, Finlay Macrae, Rupert Wing Loong Leong · 2022 · Journal of Clinical Medicine
19. Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
    Jinghao Nicholas Ngiam, Abdurrahmaan Al-Mubaarak, Sebastian Maurer‐Stroh, Paul Anantharajah Tambyah · 2022 · Singapore Medical Journal
20. Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers
    Yael Shachor‐Meyouhas, Halima Dabaja‐Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort‐Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein et al. · 2023 · Vaccines
21. Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review
    Renate Ilona Hausinger, Quirin Bachmann, Timotius Crone-Rawe, Nora Hannane, Ina Monsef, Bernhard Haller, Uwe W. Heemann, Nicole Skoetz, Nina Kreuzberger, Christoph Schmaderer · 2023 · Vaccines
22. Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction
    Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, Shota Yoshida, Satoshi Baba et al. · 2023 · Scientific Reports
23. Safety and efficacy of one and two booster doses of SARS‐CoV‐2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial
    Petr Drenko, Martin Kacer, Lukáš Kielberger, Tomáš Vlas, Ondřej Topolčan, Radek Kučera, Tomáš Reischig · 2023 · Transplant Infectious Disease
24. Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model
    Asghar Abdoli, Hamidreza Jamshidi, Mohammad Taqavian, Mehdi Lari Baghal, Hasan Jalili · 2024 · Scientific Reports
25. Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters
    Levi A. Tamming, Diana Duque, Jegarubee Bavananthasivam, Anh Tran, Casey Lansdell, Grant E. Frahm, Jianguo Wu, Emily E.F. Fekete, Marybeth Creskey, Sathya N. Thulasi Raman et al. · 2024 · Molecular Therapy — Methods & Clinical Development
26. Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster
    Ofra Amir, Yair Goldberg, Micha Mandel, Yinon M. Bar‐On, Omri Bodenheimer, Laurence S. Freedman, Sharon Alroy‐Preis, Nachman Ash, Amit Huppert, Ron Milo · 2023 · Communications Biology
27. Pre-clinical models to define correlates of protection for SARS-CoV-2
    Caolann Brady, Tom Tipton, Stéphanie Longet, Miles W. Carroll · 2023 · Frontiers in Immunology
28. Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
    Samantha Mackin, Pritesh Desai, Bradley M. Whitener, Courtney E. Karl, Meizi Liu, Ralph Steven Baric, Darin K. Edwards, Taras M. Chicz, Ryan P. McNamara, Galit Alter et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
29. Leveraging global genomic sequencing data to estimate local variant dynamics
    Zachary Susswein, Kaitlyn E. Johnson, Robel Kassa, Mina Parastaran, Vivian Peng, Leo Wolansky, Samuel V. Scarpino, Ana I. Bento · 2023 · medRxiv
30. Relative vaccine effectiveness (rVE) of mRNA COVID-19 boosters in people aged at least 75 years in the UK vaccination programme, during the Spring-Summer (monovalent vaccine) and Autumn-Winter 2022 (bivalent vaccine) booster campaigns: a prospective test negative case-control study
    Anastasia Chatzilena, Catherine J. Hyams, Robert Challen, Robin D. Marlow, Jade King, David Adegbite, Jane Kinney, Madeleine Clout, Nick A. Maskell, Jennifer Oliver et al. · 2023 · medRxiv
31. Germinal Center Response to mRNA Vaccination and Impact of Immunological Imprinting on Subsequent Vaccination
    Wooseob Kim · 2024 · Immune Network
32. Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines
    Sandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey, Bartek Nogal, Leigh M. Sewall, Alba Torrents de la Peña, Asma Rehman et al. · 2025 · Cell Reports
33. Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
    Linda Earnest, Daniel Fernandez‐Ruiz, Melissa Anne Edeling, Julio Carrera Montoya, Ashley Huey Yiing Yap, Chinn Yi Wong, Lauren E. Holz, Stéphanie Gras, Simon Collett, James P. Cooney et al. · 2026 · npj Vaccines
34. A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
    Gan Zhao, Zhiyu Zhang, Yuan Ding, Jiawang Hou, Ying Liu, Mengying Zhang, Cheng Sui, Limei Wang, Xin Xu, Xiao-Ming Gao et al. · 2023 · Vaccines
35. Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and children
    Tarfa A. Altorki, Rwaa Hussin Abdulal, Bandar A. Suliman, Talal M. Aljeraisi, Asem Alsharef, Wesam Hussain Abdulaal, Mohamed A. Alfaleh, Abdullah A. Algaissi, Rowa Y. Alhabbab, Hani Adnan Ozbak et al. · 2023 · Frontiers in Immunology
36. Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands
    Marlou J. Jongkees, Ngoc H. Tan, Daryl Geers, Rory D. de Vries, Corine H. GeurtsvanKessel, Kathryn S. Hensley, Roos S. G. Sablerolles, Susanne Bogers, Lennert Gommers, Blerdi Blakaj et al. · 2024 · AIDS
37. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age
    Tosin Omoboyede Omole, Enrique Pelayo, Aaron S. Weinberg, Spyros Chalkias, Zelalem Endale, Gretchen M. Tamms, Tina M. Sterling, Lori Good, Tulin Shekar, Morgan Johnson et al. · 2025 · Vaccines
38. Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study
    Chia-En Lien, Ming-Che James Liu, Ning‐Chi Wang, Luke Tzu-Chi Liu, Chung-Chin Wu, Wei-Hsuan Tang, Wei‐Cheng Lian, Kuan-Ying Arthur Huang, Charles Chen · 2023 · Vaccines
39. Boosting with updated COVID-19 mRNA vaccines
    Deepta Bhattacharya, Gabriel D. Victora · 2022 · Nature Medicine
40. Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
    Daniele Focosi, Fabrizio Maggi · 2022 · Viruses
41. SARS-CoV-2 Vaccine Strain Selection: Guidance From Influenza
    Arnold S. Monto, Adam S. Lauring, Emily Toth Martin · 2022 · The Journal of Infectious Diseases
42. On the End of a Nightmare (COVID-19). The Role of the Immune System
    Giulio Tarro · 2022 · British journal of healthcare and medical research
43. Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model
    Ahn Young Jeong, Pureum Lee, Moo‐Seung Lee, Doo‐Jin Kim · 2023 · Immune Network
44. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination
    Meagan C. Fitzpatrick, Seyed M. Moghadas, THOMAS NOGUEIRA VILCHES, Arnav Shah, Abhishek Pandey, Alison P. Galvani · 2023 · JAMA Network Open
45. Antiviral Drugs and Vaccines for Omicron Variant: A Focused Review
    Nidhi Garg, Ananya Sree Kunamneni, Pankaj Garg, Sandeep Sharma, Divakar Sharma, Adinarayana Kunamneni · 2023 · Canadian Journal of Infectious Diseases and Medical Microbiology
46. BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
    Rajesh M. Valanparambil, Lilin Lai, Margaret A. Johns, Meredith E. Davis-Gardner, Susanne L. Linderman, Tarrant McPherson, Andrés Chang, Akil Akhtar, Estefany Lucia Bocangel Gamarra, Hayley Matia et al. · 2023 · npj Vaccines
47. Long-Term Analyses of SARS-CoV-2 Humoral and T Cell Responses and Breakthrough SARS-CoV-2 Infections after Two Doses of BNT162b2 Followed by mRNA-1273 and Bivalent Omicron-Adapted BNT162b2 Vaccines: A Prospective Study over 2 Years in Non-Immunocompromised Individuals
    Alejo Erice, Lola Prieto, Cristina Caballero · 2023 · Vaccines
48. Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination
    Matthaios G. Speletas, Ioanna Voulgaridi, Zacharoula Bogogiannidou, Styliani Sarrou, Maria A. Kyritsi, Aikaterini Theodoridou, Katerina Dadouli, Alexia Matziri, Alexandros Vontas, Dimitra A. Pappa et al. · 2023 · Vaccines
49. Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
    George C. Kassianos, Pauline MacDonald, Ivan Aloysius, Shanti Pather · 2024 · Vaccines
50. Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray
    David Niklas Springer, Eva Höltl, Katja Prüger, Elisabeth Puchhammer‐Stöckl, Judith Helene Aberle, Karin Stiasny, Lukas Weseslindtner · 2024 · Vaccines
51. Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study
    James K. Romine, Huashi Li, Melissa M. Coughlin, Jefferson M. Jones, Amadea Britton, Harmony L. Tyner, Sammantha B Fuller, Robin F. Bloodworth, Laura Edwards, Jini N Etolue et al. · 2024 · Clinical Infectious Diseases
52. Deceptive tactics: Misappropriation of scientific literature by ‘Gazeta do Povo’ in undermining COVID-19 vaccination efforts
    Heslley Machado Silva · 2024 · Human Vaccines & Immunotherapeutics
53. Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals
    Hernan Hermes Monteiro da Costa, Valéria Oliveira Silva, Gustavo Carvalho Amorim, Marcia Grando Guereschi, Luciana Marciano Sergio, Carlos Henrique Rodrigues Gomes, Marisa Ailin Hong, Elaine Lopes de Oliveira, Luís Fernando de Macedo Brígido, José Ângelo Lauletta Lindoso et al. · 2024 · Journal of Immunological Methods
54. Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients
    Trevor Scott Johnston, Camille Hage, Aura T. Abedon, Snigdha Panda, Jennifer L. Alejo, Yolanda J. Eby, Dorry Lidor Segev, Aaron A.R. Tobian, Andrea L. Cox, William A. Werbel et al. · 2024 · Clinical Infectious Diseases
55. Safety and Immunogenicity of a PHH-1V Booster Dose after Different Prime Vaccination Schemes against Covid-19: Phase III Clinical Trial Final Results Up To One Year
    S. Martinez, Rafel Ramos, Jorge Navarro-Pérez, Maria Jesus Lopez, Maria del Mar Vazquez, José Moltó, Patricia Munoz, Jose M Echave, Jose R Arribas, Melchor Alvarez et al. · 2024 · Archives of Clinical and Biomedical Research
56. Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
    Sofia M. Gulova, Uliana S. Veselkina, Irina V. Astrakhantseva · 2025 · Vaccines
57. Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters
    Huijing Xue, Troy J. Kemp, Hayley F. North, Nancy Roche, Thomas E. Hickey, Lígia A. Pinto · 2025 · Frontiers in Immunology
58. Omicron-adapted vaccines might require longer follow-up to reveal true benefits
    Lu Tang, Ruihua Zhang, Miao Cui, Hong Peng · 2022 · The Lancet Microbe
59. Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
    Maarten Swart, Joan E. M. van der Lubbe, Sonja P. R. Schmit-Tillemans, Ella van Huizen, Johan W. A. Verspuij, Ana Izquierdo Gil, Ying Choi, Chenandly Daal, Aditya Perkasa, Adriaan H. de Wilde et al. · 2023 · npj Vaccines
60. Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
    Andrey V. Vasin, Marina Stukova · 2023 · The Lancet Infectious Diseases
61. Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future
    Zhaomu Zeng, Xiuchao Geng, Xichao Wen, Yueyue Chen, Yixi Zhu, Zishu Dong, Liangchao Hao, Tingting Wang, Jifeng Yang, Ruobing Zhang et al. · 2023 · Frontiers in Microbiology
62. COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
    Wei‐Chun Chen, Shu-Yu Hu, Ching‐Fen Shen, Hui‐Yu Chuang, Chin-Ru Ker, Ching-Ju Shen, Chao‐Min Cheng · 2023 · Vaccines
63. Bivalent Covid-19 Vaccines
    Peter W Marks, Robert M. Califf · 2023 · New England Journal of Medicine
64. Serological Response to COVID-19 Vaccination in Saudi Arabia: A Comparative Study of IgG and Neutralising Antibodies Across Vaccine Platforms
    Mariam M. AlEissa, Ahdab Alsaieedi, Reema Alduaiji, Fahad M. Almsned, Yousif M. Aldossary, Nada M. Saleh, Raghad A. AlQurashi, Esraa A. Hawsa, Muath ben shaded, Amer M. Alshehri et al. · 2025 · Vaccines
65. Perioperative SARS-CoV-2 infection and postoperative complications: a single-centre retrospective cohort study in China
    Jia Zhan, Fei Zhong, LingYan Dai, Jue Ma, YunFei Chai, XiRui Zhao, Chang Lu, YiDan Zhang, Junjiang Wang, Yong Tang et al. · 2025 · BMJ Open
66. Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals
    Seung Eui Min, Eun-Young Gu, Min Seong Jang, Young-Ju Lee, Ji‐Seok Han, Woo Ghil Lee, Seong In Jeong, Ji Young Song, In‐Chul Lee, Hyung‐Jun Kwon et al. · 2025 · Scientific Reports
67. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum
    Borja Quiroga, María José Soler, Alberto Ortíz, Patricia de Sequera · 2022 · Nefrología
68. Humoral and T-cell–mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients
    Alexandra N. Willauer, Susan D. Rouster, Heidi L. Meeds, Carrie L. Jennings, Enass A. Abdel-hameed, Diane E. Daria, Elizabeth Stambrook, Mohamed Tarek M. Shata, Kenneth E. Sherman · 2023 · Hepatology Communications
69. Humoral responses after primary and booster SARS‐CoV‐2 inactivated vaccination in patients with chronic hepatitis B virus infection: A longitudinal observational study
    Zhiwei Chen, Tianquan Huang, Taiyu He, Guanhua Zha, Qian Zhu, Gaoli Zhang, Dejuan Xiang, Min Chen, Hu Li, Ning Ling et al. · 2023 · Journal of Medical Virology
70. Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination
    Yosuke Hirotsu, Hiroki Sugiura, Mika Takatori, Hitoshi Mochizuki, Masao Omata · 2023 · Microbiology Spectrum
71. Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
    Aleha Pillay, Avani Yeola, Fiona Tea, Martina Denkova, Samuel Houston, Rebecca Burrell, Vera Merheb, Fiona X. Z. Lee, Joseph A. Lopez, Lilly Moran et al. · 2023 · Journal of Clinical Immunology
72. Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial
    Jialei Hu, Yueyue Liu, Shuo Liu, Qun Shu, Xuenan Yang, Kai Chu, Yaping Qiao, Yaling Hu, Kaiqin Wang, Hongxing Pan · 2023 · Frontiers in Immunology
73. Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
    Naomi Matsumoto, Toshiharu Mitsuhashi, Rumi Matsuo, Tomoka Kadowaki, Soshi Takao, Takashi Yorifuji · 2023 · JMA Journal
74. Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts
    Di Liu, Siyang Feng, Feng Sha, Yuxue Liao, Xu Xie, Fang Huang, Dongfeng Kong, Zhen Zhang, Zhigao Chen, Nixuan Chen et al. · 2023 · JAMA Network Open
75. Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study
    Denggao Peng, Liuqing Yang, Cheng Jin, Jiaqi Feng, Mengli Cao, Yingxia Liu · 2023 · Heliyon
76. Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity
    Xiaotong Zheng, Rong Yang, Yuxiu Zhao, Yadan Zhang, Guangying Yuan, Weidong Li, Zhuangzhuang Xiao, Xiaofei Dong, Meng Ma, Yancen Guo et al. · 2024 · Virology
77. Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2
    Joanne Reekie, Henrik Stovring, Henrik Nielsen, Işık Somuncu Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Kasper Karmark Iversen, Ahmed Basim Mustafa, Kristine Toft Petersen et al. · 2024 · International Journal of Infectious Diseases
78. A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV
    Xiaoqing Guan, Abhishek Kumar Verma, Gang Wang, Abhijeet Roy, Stanley M. Perlman, Lanying Du · 2024 · Vaccines
79. A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching
    J. Lee, Jaiprasath Sachithanandham, John S. Lee, Janna R. Shapiro, Maggie Li, Ioannis Sitaris, Stephanie R. Peralta, Camille Wouters, Andrea L. Cox, Dorry Lidor Segev et al. · 2025 · Microbiology Spectrum
80. T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells
    Ulrik Fahnøe, Shan Feng, Alexander P. Underwood, Kivin Jacobsen, Amir Ameri, Thomas Holberg Blicher, Christina Søhoel Sølund, Brad R. Rosenberg, Liselotte Brix, Nina M Weis et al. · 2025 · Frontiers in Immunology
81. Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024
    Mhairi J. McCormack, Sam Scott, Nicola Logan, Savitha Raveendran, Joseph Newman, Igor Andrade Santos, Dalan Bailey, Pablo R. Murcia, Emma C. Thomson, Margaret J. Hosie et al. · 2025 · EBioMedicine
82. Mass‐Standardised Differential Antibody Binding to a Spectrum of SARS ‐ CoV ‐2 Variant Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4/5, BA.2.75 and BA.2.12.1 Variants—Antibody Immunity Endotypes
    Philip H. James‐Pemberton, Shivali Kohli, Jordan Twynham, Aaron C. Westlake, Alex Antill, Jade Hunt, Rouslan Olkhov, Andrew M. Shaw · 2025 · Immunology
83. Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report
    Massimiliano Esposito, Giuseppe Cocimano, Fabrizio Vanaria, Francesco Sessa, Monica Salerno · 2023 · Vaccines
84. Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines
    Fan Shen, Cuixian Yang, Ying Lu, Mi Zhang, Ren‐Rong Tian, Xingqi Dong, An‐Qi Li, Yong‐Tang Zheng, Wei Pang · 2023 · Journal of Medical Virology
85. Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants
    Michael Jäger, Gabriel Diem, Sabina Sahanic, Vilmos Fux, Andrea Griesmacher, Cornelia Lass‐Flörl, Doris Wilflingseder, Ivan Tancevski, Wilfried Posch · 2023 · The Journal of Infectious Diseases
86. Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol
    Kevin Yau, Omosomi Enilama, Adeera Levin, Marc G. Romney, Joel Singer, Peter G. Blake, Jeffrey M. Perl, Jerome Allen Leis, Robert Andrew Kozak, Hubert Tsui et al. · 2023 · Canadian Journal of Kidney Health and Disease
87. Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice
    Catherine A. Cotter, Jeffrey L. Americo, Patricia L. Earl, Bernard Moss · 2023 · npj Vaccines
88. Long-term humoral response following Delta and Omicron BA.1 co-infection
    Carla Saade, Bruno Pozzetto, Melyssa Yaugel-Novoa, Guy Oriol, Laurence Josset, Bruno Lina, Stéphane Paul, Antonin Bal, Sophie Trouillet‐Assant · 2023 · npj Vaccines
89. Comparison of the immunogenicity of nasal‐spray rVSV vector, adenovirus vector, and inactivated COVID‐19‐based vaccines in rodent models
    Yuhang Zhang, Jiandong Liu, Hongyue Li, Fei Yuan, Congli Jiang, Tianle Cang, Kelei Li, Qiang Hu, Jiankai Liu, Aihua Zheng · 2023 · Journal of Medical Virology
90. Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of breakthrough infections in haemodialysis patients
    Louise Platen, Bo‐Hung Liao, Myriam Tellenbach, Cho‐Chin Cheng, Christopher Holzmann‐Littig, Catharina Christa, Christopher Dächert, Verena Kappler, Romina Bester, Maia Lucia Werz et al. · 2023 · Clinical Kidney Journal
91. Soluble SARS‐CoV ‐2 RBD and human ACE2 peptidase domain produced in Drosophila S2 cells show functions evoking virus–cell interface
    Federico Carrión, Florencia Rammauro, Natalia Olivero‐Deibe, Martín Fló, María Magdalena Portela, Analia E. Lima, Rosario Durán, Otto Pritsch, Sergio Bianchi · 2023 · Protein Science
92. Evaluation of the broad-spectrum immunogenicity of RBD dimer mRNA vaccines against SARS-CoV-2 variants
    Xu Zhao, Xinkai Wu, Pei Du, Qian Chen, Xuehui Ma, Shixiong Hu, Chunli Wu, Huiting Yang, Renyi Ma, Shuang Li et al. · 2023 · Chinese Science Bulletin (Chinese Version)
93. Sequential reinfection with Omicron variants elicits broader neutralizing antibody profiles in booster vaccinees and reduces the duration of viral shedding
    Dong Wei, Xiaoqi Yu, Yulong Li, Yingying Chen, Erzhen Chen, Ying Wang, Zhitao Yang, Xinxin Zhang · 2023 · Journal of Medical Virology
94. Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review
    Bo Yu, Christina Lauren Tamargo, Daniel C. Brennan, Sam Kant · 2023 · Vaccines
95. Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant
    Lőrinc Polivka, Istvan T. Valyi-Nagy, Zoltán Szekanecz, Krisztina Bogos, Hajnalka Vágó, Anita Kamondi, Ferenc Fekete, János Szlávik, György Surján, Orsolya Surján et al. · 2023 · Vaccines
96. Inhibitor design for TMPRSS2: insights from computational analysis of its backbone hydrogen bonds using a simple descriptor
    Suraj Ugrani · 2023 · European Biophysics Journal
97. Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins
    Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, Andrei E. Siniavin, Elena P. Mazunina, Nadezhda A. Kuznetsova, Sofia R. Kozlova, Anastasia N. Zolotar, Elena V. Shidlovskaya, Evgeny V. Usachev et al. · 2024 · Vaccines
98. Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection
    Keon Young Lee, Kyoung‐Ho Song, Kyoung Hwa Lee, Jin Yang Baek, Eu Suk Kim, Young Goo Song, Yong Chan Kim, Yoon Soo Park, Jin Young Ahn, Jun Yong Choi et al. · 2024 · Vaccine
99. Covid-19: UK will roll out Moderna’s omicron BA.1 vaccine as part of autumn booster programme
    Elisabeth Mahase · 2022 · BMJ
100. Risk factors for long COVID among healthcare workers, Brazil, 2020–2022
     Alexandre Rodrigues Marra, Vanderson de Souza Sampaio, Mina Cintho Ozahata, Rafael Lopes, Anderson Fernandes Brito, Marcelo Alves de Souza Bragatte, Jorge Elias Kalil, João Luiz Miraglia, Daniel Tavares Malheiros, Yang Guozhang et al. · 2023 · medRxiv